HIGHLIGHTS
- who: Beáta Flachner et al. from the (UNIVERSITY) have published the research: Robust Recombinant Expression of Human Placental Ribonuclease Inhibitor in Insect Cells, in the Journal: Biomolecules 2022, 273 of /2022/
- what: To our knowledge, recombinant human placenta ribonuclease inhibitor was successfully produced in baculovirus/insect cell system for the first time.
- how: The results showed that the highest amount of recombinant protein could be obtained at 2 × 106 /mL cell density.
- future: A new perspective could rise for insect derived RIs with the high success of mRNA_vaccines .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.